Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Will Withdrawal Of Generic Bupropion XL Resurrect Product Liability Litigation?

Oct 15 2012

• By Brenda Sandburg

Related Content

Generic Firms Get Supreme Shield From Product Liability, But Court Hints At Reg Change

Jun 23 2011

Generic Bupropion XL Must Be Retested; Teva/Impax 300 mg Withdrawn After Efficacy Concerns

Oct 04 2012

Post-Mensing Blues: Generic Mfrs. Still Face Product Liability Claims

Feb 20 2012

Generics Liability Bill Could Face Uphill Road In Senate

Apr 02 2012

Related Companies

Teva Pharmaceutical Industries Ltd.

Amneal Pharmaceuticals, Inc.

GSK plc

Additional Topics

United States Legal Issues BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window